
Ignacio J Amat-Santos
Latest contributions
ViV challenges in degenerated sutureless bioprosthesis
08 Apr 2025
Watch this EuroIntervention image to learn how the collision of a TAV device during valve crossing in ViV TAVI can potentially cause instability or dehiscence of the sutureless bioprosthesis, contributing to severe poorly tolerated PVL.

Late-Breaking Trial session
08 Feb 2025 – From PCR Tokyo Valves 2025
Discover the latest insights from pivotal studies in this PCR Tokyo Valves 2025 LBT session. Explore early feasibility updates from the AltaValve trial, in-hospital outcomes comparing surgical vs. percutaneous intervention in aortic stenosis with coronary artery disease from the JROAD-DPC data, and procedural results from the...

Optimising TAVI for bicuspid aortic stenosis: experience with a novel self-expanding system
26 Nov 2024 – From PCR London Valves 2024
Watch this session to explore the latest trial results and insights on treating bicuspid aortic stenosis with self-expanding valves. Learn key tips for optimal outcomes, including the importance of supra-annular assessment, appropriate sizing, and techniques to prevent underexpansion. Discover the VitaFlow specifications and clinical data, including...

Rapid-Fire - Transcatheter tricuspid valve replacement
25 Nov 2024 – From PCR London Valves 2024
Dive into a rapid-fire session showcasing the latest advancements in transcatheter tricuspid valve replacement (TTVR). Explore a case of using the LuX TTVR system to salvage a single leaflet device attachment TriClip, a unique case combining multiple interventional strategies for severe tricuspid regurgitation, and the first...

Non-transfemoral TAVI - The toolkit
25 Nov 2024 – From PCR London Valves 2024
When should you consider alternative access for TAVI instead of the transfemoral route? This video dives right into the different non-transfemoral approaches, from transsubclavian to transcaval, and explains when each technique is most appropriate.
Learn how vascular modification can expand access options for more patients and discover...

The many faces of complex TAVI
25 Nov 2024 – From PCR London Valves 2024
Learn how to navigate challenging cases illustrating the complexities of TAVI procedures and the importance of device selection and implantation technique. Discover strategies for tackling issues like bicuspid aortic stenosis, difficult access, and complex anatomies.

Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.

TAVI in bicuspid valves - Pushing the boundaries
24 Nov 2024 – From PCR London Valves 2024
Curious about the latest breakthroughs in TAVI for bicuspid aortic valve anatomy? This video dives into cutting-edge evidence from the NAVIGATE Bicuspid trial, BELIEVERS trial and the Notion 2 sub-analysis.
You'll also see a live demonstration of advanced TAVI sizing techniques and discover how Heart Teams are...

Align for the future with next-generation balloon expandable THV technology
15 May 2024 – From EuroPCR 2024
In this session, explore the next-generation balloon-expandable Myval Octacor THV, focusing on its key features, procedural impact, and potential clinical benefits. Understand the procedural steps for planning and implanting it, especially for intermediate and extra-large sizes, using the Octalign technique. Learn about the unmet clinical need...

TAVI hotline: long-term registry data
15 May 2024 – From EuroPCR 2024
This session presents and discusses long-term registry data on various aspects of transcatheter aortic valve implantation (TAVI). It covers topics such as the surgical versus transcatheter approach in combined coronary and aortic valve disease, long-term outcomes of TAVI versus surgical aortic valve replacement, and registry data...

Heterotopic tricuspid valves: to who, when and how?
15 May 2024 – From EuroPCR 2024
Watch this session to gain comprehensive insights into the use, safety, and efficacy of heterotopic tricuspid valves. Learn to identify ideal candidates with severe tricuspid regurgitation, understand key procedural factors for successful implantation, and receive tips on valve systems and anatomy. The session also includes...

TAVI in challenging anatomies
14 May 2024 – From EuroPCR 2024
Explore the complexities of TAVI in patients with intricate aortic stenosis: learn the critical role of detailed CT imaging and meticulous pre-procedural planning, and find out how to customize valve selection and implantation techniques to match unique patient anatomies, such as highly calcified tricuspid valves, low...

Supraflex Cruz - Improving patient outcomes: from simple to complex patients
14 May 2024 – From EuroPCR 2024
Discover the remarkable performance of Supraflex Cruz in real-world clinical settings, showcasing exceptionally low event rates and demonstrating its safety and efficacy across a spectrum of high-risk patients, including the elderly and those with high bleeding risks, and delve into the ongoing TALENT and TUDEXO II...

Key questions in aortic valve intervention - Anticoagulation after TAVI - when, and for whom?
21 Nov 2023 – From PCR London Valves 2023
Tune in to this session focused on post-TAVI anticoagulation, where the cases of three TAVI patients are explored. Analyze and determine the optimal antithrombotic strategy for each situation: the first patient in sinus rhythm, the second with atrial fibrillation, and the third with atrial fibrillation undergoing...

Essentials of lifetime management of TAVI patients
20 Nov 2023 – From PCR London Valves 2023
In this session, discover the key features and benefits of next-generation transcatheter heart valve technology. Gain insights into managing bicuspid and valve-in-valve interventions, and understand the procedural and clinical significance of intermediate and XL sizes in addressing unmet clinical needs.

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...

Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.

Strategic management of coronary artery disease and TAVI in patients with aortic stenosis
18 May 2023 – From EuroPCR 2023
This session offers the opportunity to explore the intricacies and nuances involved in the management of patients with aortic stenosis and coronary artery disease, providing valuable knowledge and practical insights. Gain a comprehensive understanding of the pre-operative and intra-operative aspects of TAVI through a series of...

Heterotopic valve replacement for patients with right heart failure and tricuspid regurgitation - All you need to know!
17 May 2023 – From EuroPCR 2023
Discover the comprehensive guide to heterotopic valve replacement for patients experiencing right heart failure and tricuspid regurgitation. Join this session to gain insights into patient selection criteria, delve into the concept behind this innovative procedure, and grasp the fundamental aspects of its execution.

Predicting and managing TAVI conduction related disorders
20 May 2022 – From EuroPCR 2022
Get key learnings on conduction disorders after TAVI, the role of temporary pacing devices and different strategies to reduce permanent pacemaker implants to the minimum.

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

Complex heart problems in cancer patients
19 May 2022 – From EuroPCR 2022
TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.

Stroke prevention and diagnosis
18 May 2022 – From EuroPCR 2022
Watch these videos on stroke prevention and diagnosis to learn more about the impact of pre-procedural CT on LAAC outcomes, the sex differences in safety and effectiveness of LAA closure, the temporal changes and clinical significance of peri-device leak following LAAO, and more!

PCR Valves e-Course 2020 Hotline - EXPAND G4, MyVal-1, EXPLANT-TAVR and more
24 Nov 2020 – From PCR Valves e-Course 2020
Learn more about various studies and registries:
- MitraClip G4 clinical outcome: core laboratory echo results in EXPAND G4 study
- Off-label use of transaxillary TAVI with a self-expandable device
- Safety and efficacy of next-generation balloon-expandable THV. MyVal-1 study
- Surgical EXPLANTation After TAVR Failure: subgroup analyses from the EXPLANT-TAVR international registry

TAVI: The way in, where there is no other way
05 Jun 2020
Consult this Twitter case concerning a patient with severely diseased aorta, and no options for transvascular or transapical approach who underwent self-expandable TAVI through sheathless transcaval approach

Author

Calcified left main lesion PCI
05 Jul 2019 – From AICT-AsiaPCR 2019
Consult this session to discover the key clinical data and angiographic reference of a patient presenting with calcified left main lesion PCI.

Transcatheter left atrial decompression for chronic heart failure: evidence, indications and device options
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of left atrial decompression in the multidisciplinary management of chronic heart failure, the device selection, their specifics and how to use them, and more!

Trials and registries - Long term clinical outcomes after TAVI
21 May 2019 – From EuroPCR 2019
Consult this session to learn about the latest trials and registries regarding the long term clinical outcomes after TAVI, such as CHOICE, INTeNSE, RASTAVI, and more!
